Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

GSK Takes “Blank Check” Approach To Pursuit Of Biotech Agreements

Jan 16 2006

• By The Pink Sheet

Related Content

GSK Recipe For R&D: Keep Drugs In Phase II Longer, Foster Accountability

Dec 08 2003

GSK Decreases Reliance On Late-Stage Licenses, Citing Strength In R&D

Dec 08 2003

Gardasil Goes To FDA; Merck Hopes For Mid-Year Approval Of HPV Vaccine

Dec 12 2005

GSK Oncology Pipeline Expansion Means Healthy Phase III Program In ’06

Dec 05 2005

Merck RotaTeq Observational Study For Intussusception Will Enroll 28,000

Dec 19 2005

GSK Vaccine Portfolio Gets A Shot In The Arm From ID Biomedical Buy

Sep 12 2005

GSK’s Six Launches, Six Filings Slated For ’06: Sign Of R&D Strategy Payoff?

Sep 26 2005

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window